Chemours (CC) Revenue (2014 - 2026)

Chemours' Revenue history runs 13 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• On a quarterly basis, Revenue rose 0.95% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $5.8 billion, a 0.54% increase from a year earlier, with the FY2025 full-year figure at $5.8 billion, changed 0.45% from the prior year.
• Revenue climbed to $1.4 billion in Q1 2026 per CC's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Revenue topped out at $1.9 billion in Q2 2022 and bottomed at $1.3 billion in Q4 2025.
• The 5-year median for Revenue is $1.5 billion (2023), against an average of $1.5 billion.
• Across the five-year window, Revenue advanced 22.84% in 2022 and slipped 15.53% in 2023, its largest moves.
• Year by year, Revenue stood at $1.3 billion in 2022, then climbed by 2.24% to $1.4 billion in 2023, then retreated by 0.66% to $1.4 billion in 2024, then retreated by 2.21% to $1.3 billion in 2025, then gained by 3.91% to $1.4 billion in 2026.
• Per Business Quant, the three latest CC Revenue figures stand at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.5 billion (Q3 2025).